BPI West 2022

March 14-17, 2022, San Diego, CA/ Online

Join Alira Health at BioProcess International US West to learn how to improve process efficiencies and maintain product quality across all phases of bioprocessing.

Our speaker, Bill Perry, Consultant at Alira Health, will be giving a presentation ‘From Gene to IND – Selecting a CDMO Tailored to mAbs or More Complex Biomolecules’. 

About the presentation:

For many biotech start-ups hoping to introduce new biotherapeutics, financing realities and other considerations require that they outsource to CDMOs the development, scale-up and manufacture of lead biomolecules that are to be tested clinically. Selecting and managing CDMOs for cell line and process development as well as manufacturing can be a daunting task. There are different commercially available cell lines and GMP manufacturers to evaluate, and it is critical to find the right partner who can achieve the sponsor’s target product profile on time and on budget. In this talk, I will present case studies in which I will explain the decision-making process that we use to help sponsors select CDMOs for either mAbs or more complex molecules. In addition, key considerations to manage CDMOs effectively will be discussed.

Published on:
February 2, 2022
Our Speaker
Bill Perry, Alira Health

Bill Perry

Consultant Bill is a bioprocess engineering technical leader with 17 years of experience in the industry. Over this time, he has supported multiple products at various stages of development, from pre-clinical, clinical development and manufacturing, through process validation and commercialization. He has supported biologic products, including monoclonal antibody therapeutics at Amgen and microbial fermentation therapeutics at Merck & Co. and KBI. Bill has also supported synthetic oligonucleotide products at Ophthotech and miRagen. Bill holds Bachelor’s Degrees from the University of Colorado as well as a Master’s Degree in Chemical Engineering Practice and a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology.
Our Delegate
Steven Chamow

Steven Chamow

Senior Vice President, CMC Development

Related news

Multimedia May 19, 2022
Fireside Chat Replay: Latest Developments in Oncology Supportive Care
In this fireside chat, we sit down with two medical experts in oncology and discuss some of the fascinating developments that are happening in the oncology supportive care field.
Events May 19, 2022
DIA 2022 Global Annual Meeting
We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.
Biometrics Clinical Life Sciences Regulatory
Events May 9, 2022
7e Journée start-up innovantes du dispositif médical
Clinical Digital Health Market Access MedTech Research & Development
Uncategorized May 6, 2022
U.S. and European Clinical Development for Asian MedTech Startups
This webinar will focus on the U.S. FDA and EU MDR/IVDR regulatory pathways and strategies for medical device startups based in the Asia Pacific.
Clinical MedTech
Multimedia April 28, 2022
Alira Health’s Transformation Talks: Real-World Data to Support HTAs in Europe
Learn more about RWD as a support in HTAs and its direct impact on HTAs budgets, results, and even patient outcomes by listening to this episode of Transformation Talks.
Clinical Market Access RWE
Multimedia April 15, 2022
Alira Health’s Transformation Talks: Real-World Evidence Strategy Playbook
As a special guest, our episode “Real-World Evidence Strategy Playbook” with Romain Finas, Vice President of Real-World Evidence at Alira Health, is now live! Listen to this podcast(...)
Clinical RWE
Multimedia April 13, 2022
Fireside Chat Replay: Clinical Trials in Rare Disease: Best Practices for Integrating the Patient Voice
This webinar will focus on the U.S. FDA and EU MDR/IVDR regulatory pathways and strategies for medical device startups based in the Asia Pacific.
Clinical Patient Engagement
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.